Champions Oncology Inc (NASDAQ:CSBR) Sellers Increased Their Shorts By 426.23% As Of Apr 16, 2018

April 16, 2018 - By Sheila Anderson

iShares MSCI Brazil ETF USD Acc (NASDAQ:CSBR) Corporate Logo

Change of 426.23% for Champions Oncology Inc (NASDAQ:CSBR)’s shares shorted was registered. FINRA published shares shorted of CSBR’s total 32,100 shares. Previously was reported up change of 426.23% from 6,100 shares. 1 days will cost CSBR With 43,400 average volume to recover its previous position. 0.75% is Champions Oncology Inc float short.

CSBR reached $4.08 on during the last trading session after $0.35 change.iShares MSCI Brazil ETF USD Acc has 60,441 shares volume, 94.66% up from normal. CSBR is uptrending and has moved 16.29% since April 16, 2017. The ETF outperformed the S&P 500 by 4.74%.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States.The ETF has $44.88 million market cap. The Company’s Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice.Currently it has negative earnings. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.